0№022973
ISO 13485:2016
The rapid test for the detection of COVID-19 antigen (COVID-19 Ag) is a quick and convenient method of diagnosing coronavirus infection. The test is based on the detection of SARS-CoV-2 antigen in nasopharyngeal or nasal cavity samples and gives a result in as little as 10–15 minutes.
The COVID-19 Ag rapid test is particularly relevant when employees, patients or visitors need to be checked promptly, when it is important to determine quickly whether infection is present and to reduce the risk of the disease spreading.
Advantages of the rapid test:
high sensitivity and specificity;
quick result without laboratory equipment;
simple to perform;
can be used in medical facilities and at off-site events.
The COVID-19 antigen rapid test is recommended for primary diagnosis when symptoms of acute respiratory viral infection (ARVI) appear, after contact with an infected person, or for mass screening. All products comply with the requirements of the Ministry of Health and international standards.
Infections and viruses
Immunochromatographic test for the qualitative detection of the presence of antibodies to HIV type 1, type 2 and/or subtype O and HIV p24 antigen in whole blood, serum or plasma samples.
Infections and viruses
Immunochromatographic rapid test for the visual detection of antibodies to human immunodeficiency virus in oral mucosal transudate samples in the diagnosis of HIV infection.
Infections and viruses
Immunochromatographic test for the qualitative detection of antibodies to HIV 1/2 and Treponema pallidum (TP, the causative agent of syphilis) in human whole blood, serum and plasma samples.
Infections and viruses
One-step immunochromatographic test for the qualitative detection of hepatitis B surface antigen (HBsAg) in human whole blood, serum or plasma.